ADD-How soon will new “immune therapies” become mainstream? - 101867

Spotlight
Video

ADD-How soon will new “immune therapies” become mainstream?

Loading........
Description: In this week’s video, Dr. Brian GM Durie discusses the pros and cons of newer “immune therapies,” including monoclonal antibodies, checkpoint inhibitors, bispecific antibodies, and CAR-T cells.

BOTTOM LINE:

Immune therapies are here to stay, and many will be impactful in the next few years.
Shared By : InternationalMyelomaFoundation
Posted on : 08/15/17
Added : 10 months ago
Category : Multiple Myeloma



Recommended

Nothing found.